Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Sarepta Therapeutics Inc (SRPT)

  • Event
  • June 03, 2022, 20:20 UTC
  • 11
  • 1 comments

(99% Neutral) Sarepta Therapeutics, Inc. (SRPT) Announces New Board Appointment

Comment Full text

Verrica Pharmaceuticals (VRCA)

  • Event
  • June 03, 2022, 20:16 UTC
  • 12
  • 1 comments

(99% Neutral) Verrica Pharmaceuticals Inc. (VRCA) Files Form 8-K

Comment Full text

Rain Therapeutics Inc (was acquired by Pathos AI, Inc. (“Pathos”) on 13/12/2023) (RAIN)

  • Event
  • June 03, 2022, 20:10 UTC
  • 12
  • 1 comments

(99% Neutral) Rain Therapeutics Inc. (RAIN) Files Form 8-K

Comment Full text

Ironwood Pharmaceuticals Inc (IRWD)

  • Event
  • June 03, 2022, 20:05 UTC
  • 12
  • 1 comments

(99% Neutral) IRONWOOD PHARMACEUTICALS, INC. (IRWD) Announces Regulatory Update

Comment Full text

Denali Therapeutics (DNLI)

  • Event
  • June 03, 2022, 20:01 UTC
  • 12
  • 1 comments

(99% Neutral) Denali Therapeutics Inc. (DNLI) Announces Regulatory Update

Comment Full text

Turning Point Therapeutics (the company was acquired by Bristol-Myers Squibb Company (NYSE : BMY)) (TPTX)

  • Event
  • June 03, 2022, 13:00 UTC
  • 12
  • 1 comments

(19% Negative) TURNING POINT THERAPEUTICS, INC. (TPTX) Announces Business Combination

Comment Full text

Replimune Group Inc (REPL)

  • Event
  • June 03, 2022, 12:10 UTC
  • 12
  • 1 comments

(99% Neutral) REPLIMUNE GROUP, INC. (REPL) Provides Update on announced for a variety of cancer types

Comment Full text

Novocure Ltd (NVCR)

  • Event
  • June 03, 2022, 12:01 UTC
  • 12
  • 1 comments

(85% Positive) NovoCure Limited (NVCR) Provides Update on changes for a historically difficult to treat cancer

Comment Full text

Intercept Pharmaceuticals Inc (was acquisited by Alfasigma (Italy) on 08/11/2023) (ICPT)

  • Event
  • June 03, 2022, 11:45 UTC
  • 12
  • 1 comments

(10% Negative) Intercept Pharmaceuticals, Inc. (ICPT) Announces Delay in data Trials for alkaline phosphatase (ALP) Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Comment Full text

Provention Bio Inc (the company became a subdivision of the company Sanofi ADR (SNY)) (PRVB)

  • Event
  • June 03, 2022, 11:11 UTC
  • 12
  • 1 comments

(30% Negative) PROVENTION BIO, INC. (PRVB) Announces Delay in involved Trials for his ongoing exceptional c

Comment Full text
  • Previous
  • 199
  • 200
  • 201
  • 202
  • 203
  • Next

Search

News categories

  • Technical Exchange News(10894)
  • Event(2288)
  • SEC News(189924)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124718)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin